key: cord-0853330-grx4gx95
authors: Choe, Young June
title: Coronavirus disease-19: The First 7,755 Cases in the Republic of Korea
date: 2020-03-18
journal: nan
DOI: 10.1101/2020.03.15.20036368
sha: a978eebfecc9a4eedc31b049580674f3bbb08283
doc_id: 853330
cord_uid: grx4gx95

We report the first 7,755 patients with confirmed COVID19 in Korea as of March 13, 2020. A total of 66 deaths were identified, resulting case fatality proportion of 0.9%. Older people, and those with coexisting medical conditions were at risk for fatal outcomes. The highest number of cases were from Daegu, followed by Gyeongbuk, with elevated age-stratified case fatality. This summary may help to understand the disease dynamics in the early phase of COVID19 outbreak, therefore, to guide future public health measures.

Only a few weeks after the first case of coronavirus disease 2019 (COVID-19) was noted in Wuhan, China, the first imported case of COVID-19 was confirmed in the Republic of Korea on January 20, 2020 (1) . International travel has facilitated the spread of COVID-19 throughout the world. As of March 13, 2020, 118 countries, territories, and areas have reported COVID-19 cases, however, differences in patterns and intensity of transmission ranging were observed (2) . In February and early March in Korea, a sharp increase in the number of COVID-19 cases was observed, with most infections in specific cluster and geographic region.

Based on the surveillance data, we report the basic epidemiological characteristics of COVID-19 in order to understand the early course of the pandemic. Furthermore, we investigated factors associated with deaths to provide evidence on vulnerable population for fatal outcome to guide public health prioritization.

This is a summary of the first 7,755 patients with confirmed COVID-19 in Korea as of March 13, 2020. To obtain demographic, epidemiological, and early clinical information, COVID-19 reporting and surveillance data were retrieved from Korea Centers for Disease Control and Prevention (KCDC)-operated National Notifiable Disease Surveillance System (NNDSS) (3).

Patient age was provided on the date of diagnosis, and key indicators such as estimated duration of exposure, date of onset of symptoms, and route of transmission were identified by field epidemiological investigators (1) . It must be noted that the data presented in this summary may be changed depending on the results of further epidemiological investigation. All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in 

As of March 12, 2020, a total of 7,755 laboratory-confirmed cases of COVID-19 and 66 deaths were identified in Korea, resulting case fatality proportion of 0.9% (Table 1) proportion in Daegu and Gyeongbuk were 0.8% and 1.4%, which were higher than that of Others regions with 0.4%. Figure 4 depicts age-specific epidemic curve stratified as 0-59 years and ≥60 years. The outbreak generally began with younger age group, followed by elderly population.

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in hypertension, 36.5% diabetes, 16% neurodegenerative disorders, and 17.5% pulmonary diseases. 71.2% of fatal cases were from Daegu and 24.2% were from Gyeongbuk. 5 patients were succumbed to death at home, and 11 were diagnosed to have contracted COVID-19 after death. The median interval between onset of symptom and death was 10 days (range 1-24 days), while the median interval between date of hospitalization and date of death was 5 days (range 0-16 days).

The analysis of the first 7,755 cases of COVID-19 in Korea showed a first increase of cases in specific geographic region comparable to the epidemiological situation in China and Italy (4, 5) . In Korea, despite a relevant number of cases per week in late February and early March, the peak seemed to have levelled off, yet the first wave did not go away. With descriptive analysis of interim surveillance data, the data suggest that the patient outcome differed markedly between the geographic regions, highlighting the magnitude of surge capacity on access to hospitalitzation. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted March 18, 2020. . https://doi.org/10.1101/2020.03.15.20036368 doi: medRxiv preprint parts of Korea. More severe cases were seen in elderly with coexisting condition, which warrants clear triage management and high-risk approach in healthcare access prioritization.

The COVID-19 seemed not have resulted in fatal outcome among young adults and children, however their role in disease transmission should be studies in near future.

This summary may help to understand the disease dynamics in the early phase of COVID-19 outbreak, therefore, to guide future public health measures in other countries.

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in 

Early Epidemiological and Clinical Characteristics of 28 Cases of Coronavirus Disease in South Korea

World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report -52

National Infectious Diseases Surveillance data of South Korea

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region

We thank the relevant ministries, including the Ministry of Interior and Safety, Si/Do and Si/Gun/Gu, medical staffs in health centers, and medical facilities for their efforts in responding to COVID-19 outbreak.

The authors declare no competing financial interests.All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in